Interestingly, increased expression and tumor promoting function of LGMN have been reported in several carcinomas previously such as cervical cancer [31], gastric cancer [32], oral cancer [33], breast cancer [34], neuroblastoma [35], pancreatic cancer [36], ovarian cancer [37] and melanoma [38, 39]. This evidence concerns the gene LGMN and carcinoma.